Marc-Pharma SRL
Marc-Pharma reported total assets of 36,076 € at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jul 2026).
The score of Marc-Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Marc-Pharma's annual accounts
| 2025 | |
|---|---|
| Net result | 16,193 € |
| Equity | 21,193 € |
| Cash | 51 € |
| EBITDA | 23,605 € |
| Total assets | 36,076 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jul 2026
Marc-Pharma's financial analysis
- Solvency58.7%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Marc-Pharma
Marc-Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1017.943.140
- VAT number
- BE1017943140
- Peppol
- Registered · 0208:1017943140 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Dec 2024
- Registered office
- 5651 Walcourt
- Latest accounts
- 2025 · filed on 10 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Marc-Pharma (SRL) has been based in Walcourt since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 16,193 € and equity of 21,193 €; its revenue is not published. Its solvency stands at 58.7%, above the median of its sector (41.5%).
Companies similar to Marc-Pharma
Companies in the same business, of comparable size and area, outside its group.
- Chris Pharma Works Manufacture of basic pharmaceutical products Profondeville · balance sheet 24,086 €
- Codema Pharma Retail sale of pharmaceutical products Brussels · balance sheet 375,959 €
- FLK. Society Retail sale of pharmaceutical products Namur · balance sheet 44,600 €
- Katrien Smets Retail sale of pharmaceutical products Heist-op-den-Berg · balance sheet 56,328 €
- NN Phar Retail sale of pharmaceutical products Éghezée · balance sheet 16,773 €
- Sulayman Retail sale of pharmaceutical products Enghien · balance sheet 59,800 €
- T.R.F. pharma Retail sale of pharmaceutical products Fléron · balance sheet 70,151 €
- Lisanne Moons Retail sale of pharmaceutical products Zonhoven · balance sheet 138,433 €
Frequently asked questions about Marc-Pharma
What is the revenue of Marc-Pharma?
Marc-Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Marc-Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1017943140 for Marc-Pharma, if the company is VAT-registered. Its company number (CBE) is 1017.943.140.
Where is the registered office of Marc-Pharma?
According to the CBE register, the registered office of Marc-Pharma is in 5651 Walcourt.
What is the equity of Marc-Pharma?
At the close of the 2025 financial year, the equity of Marc-Pharma amounts to 21,193 €, a solvency of 58.7% of total assets.
Who manages Marc-Pharma?
The register lists 1 active mandates at Marc-Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Marc-Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →